GGrantIndex
Sort

85,873 grants matching alzheimers

Epidemiology of Biomarkers of Risk and Progression in LOAD

$1,849,084
Richard Mayeux · Columbia University Health Sciences · R01 · FY2013 · AG

IND enabling CMC/safety/toxicology studies, submission of IND and pilot Phase 1 clinical trial with PV-1950R vaccine for Lewy Body Dementia (LBD)

$1,849,047
Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2025 · AG

Project-002

$1,848,922
Bruce T Lamb · Indiana University Indianapolis · U54 · FY2021 · AG

Molecular Mechanisms linking Aging, Abeta Proteotoxicity and Neurodegeneration

$1,848,870
Jeffery W Kelly · Scripps Research Institute, The · P01 · FY2013 · AG

Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease

$1,848,040
Bin Zhang · Icahn School Of Medicine At Mount Sinai · U01 · FY2021 · AG

UCLA Alzheimer's Disease Research Center

$1,847,659
Jeffrey L. Cummings · University Of California Los Angeles · P50 · FY2008 · AG

HEALTHY AGING AND SENILE DEMENTIA

$1,846,537
Washington University · P01 · FY2005 · AG

The Aging Brain: Vasculature, Ischemia, and Behavior

$1,846,368
Helena Chang Chui · University Of Southern California · P01 · FY2009 · AG

Identification and Characterization of Cell-Specific Transposable Elements Implicated on Alzheimer Disease and Healthy Aging

$1,846,196
Carlos Cruchaga · Washington University · R01 · FY2022 · AG

Behavioral and Neural Plasticity in the Aged

$1,845,654
Carl W Cotman · University Of California-Irvine · P01 · FY2014 · AG

Parkinson's Disease and Dementia

$1,845,465
John Q. Trojanowski · University Of Pennsylvania · P50 · FY2011 · NS

Default mode network dysfunction in Down Syndrome

$1,844,755
Elliott Jay Mufson · St. Joseph'S Hospital And Medical Center · RF1 · FY2023 · AG

Administrative Component

$1,844,340
Michael A Province · Washington University · U19 · FY2023 · AG

ADRC of the University of California, Irvine

$1,844,298
Carl W Cotman · University Of California-Irvine · P50 · FY2011 · AG

Human Blood-Brain Barrier Model for CNS Drug Translation

$1,844,274
Eric V Shusta · University Of Wisconsin-Madison · RC4 · FY2010 · AA

Behavior and Neural Plasticity in the Aged

$1,843,972
Carl W Cotman · University Of California-Irvine · P01 · FY2008 · AG

Alzheimer's Disease Research Center

$1,843,698
Mary Sano · Icahn School Of Medicine At Mount Sinai · P50 · FY2015 · AG

Neurocognitive Aging in the Monkey

$1,843,533
Peter R Rapp · National Institute On Aging · ZIA · FY2018 · AG

The relationship between early signs of small vessel disease and diffuse white matter disease through imaging biomarkers among people with risk of cognitive decline.

$1,842,635
Youngkyoo Jung · University Of California At Davis · RF1 · FY2018 · NS

Establishing the science behind Alzheimer's recruitment registries: opportunities for increasing diversity and accelerating enrollment into trials

$1,842,475
Jessica Brooke Langbaum · Banner Health · R01 · FY2023 · AG

Behavior and Neural Plasticity in the Aged

$1,840,163
Carl W Cotman · University Of California-Irvine · P01 · FY2012 · AG

Molecular Pathogenesis of Age-Dependent CNS Degeneration

$1,839,930
Stanley B Prusiner · University Of California, San Francisco · P01 · FY2006 · AG

Identifying the role of notch3 in brain pericyte function in health and Alzheimer's disease

$1,838,781
Eric V Shusta · University Of Wisconsin-Madison · RF1 · FY2023 · NS

Heterogeneity of subtle cognitive decline phenotypes in community-dwelling older adults

$1,838,200
Kelsey R Thomas · University Of California, San Diego · RF1 · FY2023 · AG

Rush Alzheimer's Disease Core Center

$1,837,081
Rush University Medical Center · P30 · FY2004 · AG